-
Product Insights
Sleep Apnea – Drugs In Development, 2023
Global Markets Direct’s, ‘Sleep Apnea - Drugs In Development, 2023’, provides an overview of the Sleep Apnea pipeline landscape. The report provides comprehensive information on the therapeutics under development for Sleep Apnea, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Obstructive Sleep Apnea – Drugs In Development, 2023
Global Markets Direct’s, ‘Obstructive Sleep Apnea - Drugs In Development, 2023’, provides an overview of the Obstructive Sleep Apnea pipeline landscape. The report provides comprehensive information on the therapeutics under development for Obstructive Sleep Apnea, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Brexanolone in Sleep Disorders
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Brexanolone in Sleep Disorders report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Brexanolone in Sleep Disorders Drug Details: Brexanolone is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PXS-4728 in Sleep Disorders
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. PXS-4728 in Sleep Disorders Drug Details: BI-1467335 (PXS-4728) is under development for the treatment of...
-
Sector Analysis
NewBronchiectasis Market Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs and Forecast to 2033
This report covers the 8MM (US, France, Germany, Italy, Spain, UK, Japan, China) and provides an Excel-based forecast model for the bronchiectasis market through 2033. Insomnia, currently represented in the International Classification of Sleep Disorders (Third Edition; ICSD-3) and the Diagnostic and Statistical Manual of Mental Disorders (Fifth Edition; DSM-5), is defined as patient-reported difficulty with sleep initiation or sleep maintenance, despite adequate opportunity and circumstances for sleep. It can include frequent awakenings, difficulty returning to sleep after awakening, or...
-
Sector Analysis
Sleep Apnea Diagnostic Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033
Sleep Apnea Diagnostic Systems Market Report Overview The Sleep apnea diagnostic systems market size was $898.8 million in 2023. The market is expected to grow at a CAGR of more than 3% during 2023-2033. Sleep apnea is a common sleeping disorder that breaks breath many times during sleep. Sleep apnea diagnostic systems include polysomnography systems (PSG systems), which is used for the screening of sleep apnea. Sleep Apnea Diagnostic Systems Market Outlook, 2023-2033 ($ Million) Buy Full Report for More...
-
Product Insights
Likelihood of Approval Analysis for Apnea
Overview How likely is it that the drugs in Apnea will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Apnea Overview Sleep apnea is a disorder that causes you to stop breathing...
-
Product Insights
Likelihood of Approval Analysis for Narcolepsy
Overview How likely is it that the drugs in Narcolepsy will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Narcolepsy Overview Narcolepsy is a sleep disorder that causes excessive sleepiness and frequent...
-
Product Insights
Likelihood of Approval Analysis for Trypanosomiasis
Overview How likely is it that the drugs in Trypanosomiasis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Trypanosomiasis Overview Trypanosomiasis, also known as sleeping sickness in humans and nagana in...